Dr. Dheeraj Kodali, MD

Dr. Kodali practices at Stockton Hematology Oncology Medical Group, Inc in Tracy, California.

Dr. Kodali's NPI, 1508179607, was assigned on July 17, 2010. Dr. Kodali graduated from Kasturba Medical College Manipal in 2009. Dr. Kodali holds California license A172284.

Dr. Kodali's primary practice is Stockton Hematology Oncology Medical Group, Inc, at 2316 Orchard Pkwy, Tracy, CA 95377 in San Joaquin County. The practice phone is (209) 466-2626.

Dr. Kodali's primary practice is Stockton Hematology Oncology Medical Group, Inc in Tracy, California. Dr. Kodali is also affiliated with Sutter Tracy Community Hospital. The medical group on file is Stockton Hematology Oncology. Dmand AI also links Dr. Kodali to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kodali practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kodali's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kodali is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kodali's licenses on file in 3 states: California, West Virginia and Kentucky.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Kodali treats.

CMS data shows 29,367 Medicare services from Dr. Kodali across 24 procedure codes in 2024, for 331 Medicare patients. Medicare paid $232,110 for them.

CMS counts 331 Medicare patients who saw Dr. Kodali in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kodali's median patient age at 69, with 60% women.

In 2024, Dr. Kodali wrote 1,601 Medicare Part D claims for 253 patients. 80% of them were for generic drugs. CMS names the drug for 1,286 of them, across 45 drugs with 11 or more claims each, at $3,374,302 in total drug cost. In 2023, CMS named 987 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kodali for performance year 2024, reported as part of a group. Dr. Kodali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kodali as offering telehealth.

Dmand AI links 3 papers to Dr. Kodali, published from 2016 to 2018. 2018 was the busiest year, with 2. Dr. Kodali's most frequent co-authors are Narendranath Epperla, MD, Timothy S. Fenske, MD and Veronika Bachanova, MD.

CMS Open Payments shows 252 general payments to Dr. Kodali from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Novartis Pharmaceuticals Corporation paid the most, $575.

Dr. Kodali graduated from Kasturba Medical College Manipal in 2009.

Dr. Kodali is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.